N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline
C56H42N2 — CID 144830813
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline
N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline (PubChem CID 144830813) has the molecular formula C56H42N2 and a molecular weight of 742.97 g/mol. Its IUPAC name is N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline.
Molecular Properties
| Compound Name | N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline |
|---|---|
| PubChem CID | 144830813 |
| Molecular Formula | C56H42N2 |
| Molecular Weight | 742.97 g/mol |
| Exact Mass | 742.33 |
| IUPAC Name | N-[4-[2-[2-(2-benzylphenyl)-3-methylphenyl]carbazol-9-yl]phenyl]-N,4-diphenylaniline |
| SMILES | Cc1cccc(-c2ccc3c4ccccc4n(-c4ccc(N(c5ccccc5)c5ccc(-c6ccccc6)cc5)cc4)c3c2)c1-c1ccccc1Cc1ccccc1 |
| InChI | InChI=1S/C56H42N2/c1-40-16-15-26-51(56(40)50-24-12-11-21-44(50)38-41-17-5-2-6-18-41)45-30-37-53-52-25-13-14-27-54(52)58(55(53)39-45)49-35-33-48(34-36-49)57(46-22-9-4-10-23-46)47-31-28-43(29-32-47)42-19-7-3-8-20-42/h2-37,39H,38H2,1H3 |
| InChIKey | XPYMRHSPLCTMQD-UHFFFAOYSA-N |
| XLogP | 15.15 |
| TPSA | 8.17 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 742.97 |
| LogP ≤ 5 | 15.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144830813 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.